Skip to main content
SpringerLink
Log in

Cardiovascular Disease

  • Chapter
Geriatric Medicine

Conclusion

In planning for health care in the twenty-first century, the increased proportion of elderly patients, who often will have cardiovascular disease and often will require advanced technology diagnostic and therapeutic interventions, must be addressed.323 Comparison must be made of the resources required for and outcomes of palliative care if sophisticated techniques are not under-taken. The use of health care resources will increase not only with increasing age but with the improved expectations of older persons about their health status.

At the same time, it will be necessary to avoid overzealous and redundant diagnostic and therapeutic measures. Data are needed to define interventions at old and very old age that favorably affect morbidity and mortality, functional status, and other meaningful quality of life attributes. Preventive aspects will increasingly become important components of care for elderly cardiac patients, and require the development of cost-effective preventive strategies, although it remains uncertain how much extension of years of health and decrease in disability can be anticipated in later life. The decline in premature cardiovascular mortality in recent decades appears an important component in the longevity of the elderly population; however, it is not certain whether the effect of preventive efforts in limiting or delaying cardiovascular disease will ultimately decrease overall health care costs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 379.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wenger NK, ed. Cardiovascular Disease in the Octogenarian and Beyond. London: Dunitz, 1999.

    Google Scholar 

  2. National Center for Health Statistics. Advance Report of Final Mortality Statistics, 1988. Monthly Vital Statistics Report, vol 39, no. 7 (suppl). Hyattsville, MD: Public Health Service; 1990:1–48.

    Google Scholar 

  3. Riley G, Lubitz J, Prihoda R, et al. The use and costs of Medicare services by cause of death. Inquiry. 1987;24:233–244.

    PubMed  CAS  Google Scholar 

  4. Gerson LW, Skvarch L. Emergency medical service utilization by the elderly. Ann Emerg Med. 1982;11:610–612.

    Article  PubMed  CAS  Google Scholar 

  5. Mittelmark MB, Psaty BM, Rautaharju PM, et al. Prevalence of cardiovascular diseases among older adults: the Cardiovascular Health Study. Am J Epidemiol. 1993;137: 311–317.

    PubMed  CAS  Google Scholar 

  6. Cheitlin MD, Gerstenblith G, Hazzard WR, et al. Do existing databases answer clinical questions about geriatric cardiovascular disease and stroke? Am J Geriatr Cardiol. 2001;10:207–223.

    PubMed  CAS  Google Scholar 

  7. Bild DE, Fitzpatrick A, Fried LP, et al. Age-related trends in cardiovascular morbidity and physical functioning in the elderly: The Cardiovascular Health Study. J Am Geriatr Soc. 1993;41:1047–1056.

    PubMed  CAS  Google Scholar 

  8. Corti M-C, Salive ME, Guralnik JM. Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons. J Clin Epidemiol. 1996;49:519–526.

    Article  PubMed  CAS  Google Scholar 

  9. Sollott SJ, Lakatta EG. Normal aging changes in the cardiovascular system. Cardiol Elderly. 1993;1:349–358.

    Google Scholar 

  10. Fleg JL, Lakatta EG. Role of muscle loss in the age-associated reduction in VO2 max. J Appl Physiol. 1988;65:1147–1151.

    PubMed  CAS  Google Scholar 

  11. Lernfelt B, Wikstrand J, Svanborg A, et al. Aging and left ventricular function in elderly healthy people. Am J Cardiol. 1991;68:547–549.

    Article  PubMed  CAS  Google Scholar 

  12. Mader SL, Josephson KR, Rubenstein LZ. Low prevalence of postural hypotension among community-dwelling elderly. JAMA. 1987;258:1511–1514.

    Article  PubMed  CAS  Google Scholar 

  13. Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults. The Cardiovascular Health Study. Hypertension. 1992;19(part 1):508–519.

    PubMed  CAS  Google Scholar 

  14. Bharati S, Lev M. Pathologic changes of the conduction system with aging. Cardiol Elderly. 1994;2:152–160.

    Google Scholar 

  15. Lindroos M, Kupari M, Heikkilä J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220–1225.

    PubMed  CAS  Google Scholar 

  16. Ooi WL, Barrett S, Hossain M, et al. Patterns of orthostatic blood pressure change an their clinical correlates in a frail, elderly population. JAMA. 1997;277:1299–1304.

    Article  PubMed  CAS  Google Scholar 

  17. Newman AB, Siscovick DS, Manolio TA, et al., for the Cardiovascular Health Study (CHS) Collaborative Research Group. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation. 1993;88:837–845.

    PubMed  CAS  Google Scholar 

  18. Otto CM, Lind BK, Kitzman DW, et al., for the Cardiovascular Health Study. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142–147.

    Article  PubMed  CAS  Google Scholar 

  19. Rautaharju PM, Manolio TA, Psaty BM, et al., for the Cardiovascular Health Study Collaborative Research Group. Correlates of QT prolongation in older adults (the Cardiovascular Health Study). Am J Cardiol. 1994;73:999–1002.

    Article  PubMed  CAS  Google Scholar 

  20. de Bruyne MC, Hoes AW, Kors JA, et al. QTc dispersion predicts cardiac mortality in the elderly. The Rotterdam Study. Circulation. 1998;97:467–472.

    PubMed  Google Scholar 

  21. Casiglia E, Maniati G, Daskalakis C, et al. Left-ventricular hypertrophy in the elderly: unreliability of ECG criteria in 477 subjects aged 65 years or more: the CArdiovascular STudy in the ELderly (CASTEL). Cardiology. 1996;87:429–435.

    PubMed  CAS  Google Scholar 

  22. Furberg CD, Manolio TA, Psaty BM, et al., for the Cardiovascular Health Study Collaborative Research Group. Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Am J Cardiol. 1992;69:1329–1335.

    Article  PubMed  CAS  Google Scholar 

  23. Ingerslev J, Bjerregaard P. Prevalence and prognostic significance of cardiac arrhythmias detected by ambulatory electrocardiography in subjects 85 years of age. Eur Heart J. 1986;7:570–575.

    PubMed  CAS  Google Scholar 

  24. Come PC, Riley MF, McKay RG, et al. Echocardiographic assessment of aortic valve area in elderly patients with aortic stenosis and of changes in valve area after percuta neous balloon valvuloplasty. J Am Coll Cardiol. 1987;10: 115–124.

    PubMed  CAS  Google Scholar 

  25. Goraya TY, Jacobsen SJ, Pellikka PA, et al. Prognostic value of treadmill exercise testing in elderly persons. Ann Intern Med. 2000;132:862–870.

    PubMed  CAS  Google Scholar 

  26. Deckers JW, Simoons ML, Fioretti P. The value of exercise testing in elderly patients. Geriatr Cardiovasc Med 1988;1: 89–93.

    Google Scholar 

  27. Iskandrian AS, Heo J, Decoskey D, et al. Use of exercise thallium-201 imaging for risk stratification of elderly patients with coronary artery disease. Am J Cardiol. 1988; 61:269–272.

    Article  PubMed  CAS  Google Scholar 

  28. Hilton TC, Shaw LJ, Chaitman BR, et al. Prognostic significance of exercise thallium-201 testing in patients aged ≥70 years with known or suspected coronary artery disease. Am J Cardiol. 1992;69:45–50.

    Article  PubMed  CAS  Google Scholar 

  29. Lam JYT, Chaitman BR, Glaenzer M. Safety and diagnostic accuracy in dipyridamole-thallium imaging in the elderly. J Am Coll Cardiol. 1988;11:585–589.

    PubMed  CAS  Google Scholar 

  30. Gersh BJ, Kronmal RA, Frye RL, et al. Coronary arteriography and coronary artery bypass surgery: morbidity and mortality in patients age 65 years or older. A report from the Coronary Artery Surgery Study. Circulation. 1983;67:483–491.

    PubMed  CAS  Google Scholar 

  31. Clark VL, Khaja F. Risk of cardiac catheterization in patients age ≥80 years without previous cardiac surgery. Am J Cardiol. 1994;74:1076–1077.

    Article  PubMed  CAS  Google Scholar 

  32. Williams JF, Bristow MR, Fowler MB, et al. Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation. 1995;92:2764–2784.

    Google Scholar 

  33. Smith WM. Epidemiology of congestive heart failure. Am J Cardiol. 1985;55:3A–8A.

    Article  PubMed  CAS  Google Scholar 

  34. McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham Study. N Engl J Med. 1971;285:1441–1446.

    Article  PubMed  CAS  Google Scholar 

  35. Croft JB, Giles WH, Pollard RA, et al. Heart failure survival among older adults in the United States. A poor prognosis for an emerging epidemic in the Medicare population. Arch Intern Med. 1999;159:505–510.

    Article  PubMed  CAS  Google Scholar 

  36. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol. 1996; 27:1214–1218.

    Article  PubMed  CAS  Google Scholar 

  37. Rich MW, Shah AS, Vinson JM, et al. Iatrogenic congestive heart failure in older adults: clinical course and prognosis. J Am Geriatr Soc. 1996;44:638–643.

    PubMed  CAS  Google Scholar 

  38. Konstam MA, Dracup K, Baker D, et al. Heart Failure: Evaluation and Care of Patients with Left-Ventricular Systolic Dysfunction. Clinical Practice Guideline No. 11. AHCPR Pub 94-0612. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S.Department of Health and Human Services; June 1994.

    Google Scholar 

  39. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol. 1995;26:1565–1574.

    Article  PubMed  CAS  Google Scholar 

  40. Wong WF, Gold S, Fukuyama O, et al. Diastolic dysfunction in elderly patients with congestive heart failure. Am J Cardiol. 1989;63:1526–1528.

    Article  PubMed  CAS  Google Scholar 

  41. Senni M, Tribouilloy CM, Rodeheffer RJ. Congestive heart failure in the community. A study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998;98:2282–2289.

    PubMed  CAS  Google Scholar 

  42. van Kraaij DJW, Jansen RWMM, Bouwels LHR, et al. Furosemide withdrawal improves postprandial hypotension in elderly patients with heart failure and preserved left ventricular systolic function. Arch Intern Med. 1999; 159:1599–1605.

    Article  PubMed  Google Scholar 

  43. Kessler KM. Heart failure with normal systolic function. Update of prevalence, differential diagnosis, prognosis and therapy [editorial]. Arch Intern Med. 1988;148:2109–2111.

    Article  PubMed  CAS  Google Scholar 

  44. Cody RJ, Torre S, Clark M, et al. Age-related hemodynamic, renal, and hormonal differences among patients with congestive heart failure. Arch Intern Med. 1989;149:1023–1028.

    Article  PubMed  CAS  Google Scholar 

  45. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429–1435.

    Article  Google Scholar 

  46. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293–302.

    Article  Google Scholar 

  47. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303–310.

    Article  PubMed  CAS  Google Scholar 

  48. Chapman D, Wang T, Gheorghiade M. Therapeutic approaches to heart failure in elderly patients. Cardiol Elderly. 1994;2:89–97.

    Google Scholar 

  49. Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992;327:669–677.

    Article  PubMed  CAS  Google Scholar 

  50. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigations. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821–828.

    Google Scholar 

  51. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med. 1986;314:1547–1552.

    Article  PubMed  CAS  Google Scholar 

  52. De Bock V, Mets T, Romagnoli M, et al. Captopril treatment of chronic heart failure in the very old. J Gerontol. 1994;49:M148–M152.

    PubMed  Google Scholar 

  53. Pitt B, Segal R, Martinez FA, et al., on behalf of the ELITE Study Investigators. Randomised trial of losartan versus captopril in patients over 65 with heart failure. Evaluation of Losartan in the Elderly Study, ELITE. Lancet. 1997; 349:747–752.

    Article  PubMed  CAS  Google Scholar 

  54. Pitt B for the ELITE II Investigators. Randomized evaluation of losartan compared to captopril in elderly patients with heart failure: ELITE II. Presented at the American Heart Association 72nd Annual Scientific Sessions, Atlanta, GA, November 1999.

    Google Scholar 

  55. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–1355.

    Article  PubMed  CAS  Google Scholar 

  56. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomised trial. Lancet 1999;353:9–13.

    Article  Google Scholar 

  57. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353: 2001–2007.

    Google Scholar 

  58. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactoneon morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709–717.

    Article  PubMed  CAS  Google Scholar 

  59. Krumholz HM, Wang Y, Parent EM, et al. Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med. 1997;157:2242–2247.

    Article  PubMed  CAS  Google Scholar 

  60. Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADI-ANCE Study. N Engl J Med. 1993;329:1–7.

    Article  PubMed  CAS  Google Scholar 

  61. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525–533.

    Article  Google Scholar 

  62. Giannuzzi P, Tavazzi L, Temporelli PL, et al., for the EAMI Study Group. Long-term physical training and left ventricular remodeling after anterior myocardial infarction: Results of the Exercise in Anterior Myocardial Infarction (EAMI) Trial. J Am Coll Cardiol. 1993;22:1821–1829.

    PubMed  CAS  Google Scholar 

  63. Wenger NK, Froelicher ES, Smith LK, et al. Cardiac Rehabilitation. Clinical Practice Guideline No. 17. AHCPR Pub 96-0672. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research and the National Heart, Lung, and Blood Institute; October 1995.

    Google Scholar 

  64. Pearson AC, Gudipati CV, Labovitz AJ. Systolic and diastolic flow abnormalities in elderly patients with hypertensive hypertrophic cardiomyopathy. J Am Coll Cardiol. 1988;12:989–995.

    PubMed  CAS  Google Scholar 

  65. Rich MW. Beckham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995; 333:1190–1195.

    Article  PubMed  CAS  Google Scholar 

  66. Rich MW, Gray DB, Beckham V, et al. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med. 1996;101:270–276.

    Article  PubMed  CAS  Google Scholar 

  67. Kornowski R, Zeeli D, Averbuch M, et al. Intensive home-care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure. Am Heart J. 1995;129:762–766.

    Article  PubMed  CAS  Google Scholar 

  68. Krumholz HM, Butler J, Miller J, et al. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation. 1998;97:958–964.

    PubMed  CAS  Google Scholar 

  69. Kobashigawa JA. Early and late complications in the elderly heart transplant recipient. Cardiol Elderly. 1996;4:15–21.

    Google Scholar 

  70. Martin A, Benbow LJ, Butrous GS. Five-year follow-up of 101 elderly subjects by means of long-term ambulatory cardiac monitoring. Eur Heart J. 1984;5:592–596.

    PubMed  CAS  Google Scholar 

  71. Fleg JL, Kennedy HL. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. Chest. 1982;81:302–307.

    PubMed  CAS  Google Scholar 

  72. Kantelip JP, Sage E, Duchene-Marullaz P. Findings on ambulatory electrocardiographic monitoring in subjects older than 80 years. Am J Cardiol. 1986;57:398–401.

    Article  PubMed  CAS  Google Scholar 

  73. Lipsitz LA, Wei JY, Rowe JW. Syncope in an elderly, institutionalized population: prevalence, incidence, and associated risk. Q J Med. 1985;55:45–54.

    PubMed  CAS  Google Scholar 

  74. Gordon M, Huang M, Gryfe CI. An evaluation of falls, syncope, and dizziness in prolonged ambulatory cardiographic monitoring in a geriatric institutional setting. J Am Geriatr Soc. 1982;30:6–12.

    PubMed  CAS  Google Scholar 

  75. Manolio TA, Furberg CD, Rautaharju PM, et al., for the Cardiovascular Health Study (CHS) Collaborative Research Group. Cardiac arrhythmias on 24-h ambulatory electrocardiography in older women and men. The Cardiovascular Health Study. J Am Coll Cardiol. 1994;23: 916–925.

    PubMed  CAS  Google Scholar 

  76. Ryder KM, Benjamin EJ. Epidemiology and significance of atrial fibrillation. Am J Cardiol. 1999;84:131R–138R.

    Article  PubMed  CAS  Google Scholar 

  77. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. Arch Intern Med. 1987;147:1561–1564.

    Article  PubMed  CAS  Google Scholar 

  78. Furberg CD, Psaty BM, Manolio TA, et al., for the Cardiovascular Health Study (CHS) Collaborative Research Group. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol. 1994;74:236–241.

    Article  PubMed  CAS  Google Scholar 

  79. Benjamin EJ, Wolf PA, D’Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–952.

    PubMed  CAS  Google Scholar 

  80. Carlsson J, Tebbe U, Rox J, et al., for the ALKK-Study Group. Cardioversion of atrial fibrillation in the elderly. Am J Cardiol. 1996;78:1380–1384.

    Article  PubMed  CAS  Google Scholar 

  81. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: final results. Circulation. 1991;84:527–539.

    Google Scholar 

  82. Petersen P, Boysen G, Godtfredsen J, et al. Placebocontrolled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet. 1989;1:175–179.

    Article  PubMed  CAS  Google Scholar 

  83. White RH, McBurnie MA, Manolio T, et al. Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort. Am J Med. 1999;106:165–171.

    Article  PubMed  CAS  Google Scholar 

  84. Frishman WH, Heiman M, Karpenos A, et al. Twenty-four-hour ambulatory electrocardiography in elderly subjects: prevalence of various arrhythmias and prognostic implications. Report from the Bronx Longitudinal Aging Study. Am Heart J. 1996;132:297–302.

    Article  PubMed  CAS  Google Scholar 

  85. Josephson RA, Papa LA, Brooks MM, et al., for the CAST Investigators. Effect of age on postmyocardial infarction ventricular arrhythmias (Holter registry data from CAST I and CAST II). Am J Cardiol. 1995;76:710–713.

    Article  PubMed  CAS  Google Scholar 

  86. Mercando AD, Aronow WS, Epstein S, et al. Signal-averaged electrocardiography and ventricular tachycardia as predictors of mortality after acute myocardial infarction in elderly patients. Am J Cardiol. 1995;76:436–440.

    Article  PubMed  CAS  Google Scholar 

  87. Aronow WS, Mercando AD, Epstein S. et al. Effect of quinidine or procainamide versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in elderly patients with heart disease and complex ventricular arrhythmias. Am J Cardiol. 1990;66: 423–428.

    Article  PubMed  CAS  Google Scholar 

  88. Tresch DD, Troup PJ, Thakur RK, et al. Comparison of efficacy of automatic implantable cardioverter defibrillator in patients older and younger than 65 years of age. Am J Med. 1991;90:717–724.

    PubMed  CAS  Google Scholar 

  89. Zado ES, Callans DJ, Gottlieb CD, et al. Efficacy and safety of catheter ablation in octogenarians. J Am Coll Cardiol. 2000;35:458–462.

    Article  PubMed  CAS  Google Scholar 

  90. Kalusche D, Ott P, Arentz T, et al. AV nodal re-entry tachycardia in elderly patients: clinical presentation and results of radiofrequency catheter ablation therapy. Coronary Artery Dis. 1998;9:359–363.

    CAS  Google Scholar 

  91. Shen W-K, Hayes DL. Pacing the octogenarians and nonagenarians: should age be a consideration for pacing and outcome analysis of pacing in the very elderly? Cardiol Elderly. 1994;2:161–170.

    Google Scholar 

  92. Shen W-K, Hayes DL, Hammill SC, et al. Survival and functional independence after implantation of a permanent pacemaker in octogenarians and nonagenarians. A population-based study. Ann Intern Med. 1996;125:476–480.

    PubMed  CAS  Google Scholar 

  93. Channon KM, Hargreaves MR, Cripps TR, et al. DDD vs VVI pacing in patients aged over 75 years with complete heart block: a double-blind crossover comparison. Q J Med. 1994;87:245–251.

    PubMed  CAS  Google Scholar 

  94. Lamas GA, Pashos CL, Normand S-LT, et al. Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. Circulation. 1995;91: 1063–1069.

    PubMed  CAS  Google Scholar 

  95. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol. 1998;31:1175–1209.

    Article  PubMed  CAS  Google Scholar 

  96. Panotopoulos PT, Axtell K, Anderson AJ, et al. Efficacy of the implantable cardioverter-defibrillator in the elderly. J Am Coll Cardiol. 1997;29:556–560.

    Article  PubMed  CAS  Google Scholar 

  97. Tresch DD. CPR in the elderly: when should it be performed? Geriatrics. 1991;46:47–56.

    PubMed  CAS  Google Scholar 

  98. Dawson DA, Adams PF. Current Estimates from the National Health Interview Survey, United States, 1986. Vital and Health Statistics, Series 10, No 164. Department of Health and Human Services Publication PHS 87-1592. Hyattsville, MD: National Center for Health Statistics, Public Health Service; 1987:98.

    Google Scholar 

  99. Wenger NK, Furberg CD, Pitt E. Coronary Heart Disease in the Elderly. Working Conference on the Recognition and Management of Coronary Heart Disease in the Elderly, National Institutes of Health, Bethesda 1985. New York: Elsevier; 1986.

    Google Scholar 

  100. Graves EJ. Summary, 1989 National Hospital Discharge Survey: Advance Data from Vital and Health Statistics No 199. Hyattsville, MD: National Center for Health Statistics; 1991:1–12.

    Google Scholar 

  101. Psaty BM, Furberg CD, Kuller LH, et al. Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study. Arch Intern Med. 1999;159:1339–1347.

    Article  PubMed  CAS  Google Scholar 

  102. Pepine CJ, Abrams J, Marks RG, et al., for the TIDES Investigators. Characteristics of a contemporary population with angina pectoris. Am J Cardiol. 1994;74:226–231.

    Article  PubMed  CAS  Google Scholar 

  103. Umachandran V, Ranjadayalan K, Ambepityia G, et al. Aging, autonomic function, and the perception of angina. Br Heart J. 1991;66:15–18.

    PubMed  CAS  Google Scholar 

  104. LaCroix AZ, Guralnik JM, Curb JD, et al. Chest pain and coronary heart disease mortality among older men and women in three communities. Circulation. 1990;81:437–446.

    PubMed  CAS  Google Scholar 

  105. Stone PH, Thompson B, Anderson HV, et al., for the TIMI III Registry Study Group. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: the TIMI III Registry. JAMA. 1996; 275:1104–1112.

    Article  PubMed  CAS  Google Scholar 

  106. Marcus FI, Friday K, McCans J, et al. Age-related prognosis after acute myocardial infarction (the Multicenter Diltiazem Postinfarction trial). Am J Cardiol. 1990;65:559–566.

    Article  PubMed  CAS  Google Scholar 

  107. American Heart Association National Center. Vital Statistics of the United States. Dallas, TX: American Heart Association; 1995.

    Google Scholar 

  108. Vaccarino V, Berkman LF, Mendes de Leon CF, et al. Functional disability before myocardial infarction in the elderly as a determinant of infarction severity and postinfarction mortality. Arch Intern Med. 1997;157:2196–2204.

    Article  PubMed  CAS  Google Scholar 

  109. Devlin W, Cragg D, Jacks M, et al. Comparison of outcome in patients with acute myocardial infarction aged >75 years with that in younger patients. Am J Cardiol. 1995;75: 573–576.

    Article  PubMed  CAS  Google Scholar 

  110. Krumholz HM, Murillo JE, Chen J, et al. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA. 1997;277:1683–1688.

    Article  PubMed  CAS  Google Scholar 

  111. Weaver WD, Litwin PE, Martin JS, et al., the MITI Project Group. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. J Am Coll Cardiol. 1991;18:657–662.

    PubMed  CAS  Google Scholar 

  112. Wolinsky FD, Wyrwich KW, Gurney JG. Gender differences in the sequelae of hospitalization for acute myocardial infarction among older adults. J Am Geriatr Soc. 1999; 47:151–158.

    PubMed  CAS  Google Scholar 

  113. Vaccarino V, Parsons L, Every NR, et al., for the National Registry of Myocardial Infarction 2 Participants. Sex-based differences in early mortality after myocardial infarction. N Engl J Med. 1999;341:217–225.

    Article  PubMed  CAS  Google Scholar 

  114. Nadelmann J, Frishman WH, Ooi WL, et al. Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: the Bronx Aging Study. Am J Cardiol. 1990;66:533–537.

    Article  PubMed  CAS  Google Scholar 

  115. Solomon CG, Lee TH, Cook EF, et al., for the Chest Pain Study Group. Comparison of clinical presentation of acute myocardial infarction in patients older than 65 years of age to younger patients: the Multicenter Chest Pain Study experience. Am J Cardiol. 1989;63:772–776.

    Article  PubMed  CAS  Google Scholar 

  116. Svanborg A, Bergstrom G, Mellstrom D. Epidemiological Studies on Social and Medical Conditions of the Elderly. European Reports and Studies 62. Copenhagen: WHO Regional Office for Europe; 1982.

    Google Scholar 

  117. Gurwitz JH, McLaughlin TJ, Willison DJ, et al. Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med. 1997;126:593–599.

    PubMed  CAS  Google Scholar 

  118. Paul SD, O’Gara PT, Mahjoub ZA, et al. Geriatric patients with acute myocardial infarction: cardiac risk factor profiles, presentation, thrombolysis, coronary interventions, and prognosis. Am Heart J. 1996;131:710–715.

    Article  PubMed  CAS  Google Scholar 

  119. Hong RA, Licht JD, Wei JY, et al. Elevated CK-MB with normal total creatine kinase in suspected myocardial infarction: associated clinical findings and early prognosis. Am Heart J. 1986;111:1041–1047.

    Article  PubMed  CAS  Google Scholar 

  120. Gruppo Italiano per lo Studio della Streptochinasi nelľInfarto Miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet. 1987;ii:871–874.

    Google Scholar 

  121. Wilcox RG, Von der Lippe G, Olsson CG, et al., for the Anglo-Scandinavian Study of Early Thrombolysis. Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Lancet. 1990;335:1175–1178.

    PubMed  CAS  Google Scholar 

  122. AIMS Trial Study Group: Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. Lancet. 1990;335:427–431.

    Article  Google Scholar 

  123. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311–322.

    Google Scholar 

  124. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1996;28:1328–1428.

    Article  PubMed  CAS  Google Scholar 

  125. Chaitman BR, Thompson B, Wittry MD, et al. The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from Thrombolysis in Myocardial Infarction Phase I, open label studies, and the Thrombolysis in Myocardial Infarction Phase II pilot study. J Am Coll Cardiol. 1989;14:1159–1165.

    Article  PubMed  CAS  Google Scholar 

  126. The International Study Group. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. Lancet. 1990;336: 71–75.

    Article  Google Scholar 

  127. Gruppo Italiano per lo Studio della Sopravvivenza nelľInfarto Miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet. 1990;336:65–71.

    Google Scholar 

  128. Gore JM, Sloan M, Price TR, et al. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study: Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. Circulation. 1991;83:448–459.

    PubMed  CAS  Google Scholar 

  129. White HD, Barbash GI, Califf RM, et al., for the GUSTO-I Investigators. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Circulation. 1996;94:1826–1833.

    PubMed  CAS  Google Scholar 

  130. Lesnefsky EJ, Lundergan CF, Hodgson JMB, et al. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience. J Am Coll Cardiol. 1996;28:331–337.

    Article  PubMed  CAS  Google Scholar 

  131. Pfeffer MA, Moye LA, Braunwald E, et al. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators. JAMA. 1991;266:528–532.

    Article  PubMed  CAS  Google Scholar 

  132. McLaughlin TJ, Gurwitz JH, Willison DJ, et al. Delayed thrombolytic treatment of older patients with acute myocardial infarction. J Am Geriatr Soc. 1999;45:1222–1228.

    Google Scholar 

  133. Tresch DD, Brady WJ, Aufderheide TP, et al. Comparison of elderly and younger patients with out-of-hospital chest pain: clinical characteristics, acute myocardial infarction, therapy, and outcomes. Arch Intern Med. 1996;156:1089–1093.

    Article  PubMed  CAS  Google Scholar 

  134. Newby LK, Rutsch WR, Califf RM, et al., for the GUSTO-I Investigators. Time from symptom onset to treatment and outcomes after thrombolytic therapy. J Am Coll Cardiol. 1996;27:1646–1655.

    Article  PubMed  CAS  Google Scholar 

  135. Gurwitz JH, Gore JM, Goldberg RJ, et al., for the Participants in the National Registry of Myocardial Infarction. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. Ann Intern Med. 1996;124:283–291.

    PubMed  CAS  Google Scholar 

  136. Maggioni AP, Maseri A, Fresco C, et al., on behalf of the Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nelľInfarto Miocardico (GISSI-2). Agerelated increase in mortality among patients with first myocardial infarctions treated with thrombolysis. N Engl J Med. 1993;329:1442–1448.

    Article  PubMed  CAS  Google Scholar 

  137. Thiemann DR, Coresh J, Schulman SP, et al. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation. 2000;101:2239–2246.

    PubMed  CAS  Google Scholar 

  138. Ayanian JZ, Braunwald E. Thrombolytic therapy for patients with myocardial infarction who are older than 75 years. Do the risks outweigh the benefits? [editorial]. Circulation. 2000;101:2224–2226.

    PubMed  CAS  Google Scholar 

  139. The GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet. 2001;357:1905–1914.

    Article  Google Scholar 

  140. Berger AK, Schulman KA, Gersh BJ, et al. Primary coronary angioplasty vs thrombotysis for the management of acute myocardial infarction in elderly patients. JAMA. 1999;282:341–348.

    Article  PubMed  CAS  Google Scholar 

  141. Holmes DR Jr, White HD, Pieper KS, et al. Effect of age on outcome with primary angioplasty versus thrombolysis. J Am Coll Cardiol. 1999;33:412–419.

    Article  PubMed  Google Scholar 

  142. Forman DE, Bernal JLG, Wei JY. Management of acute myocardial infarction in the very elderly. Am J Med. 1992; 93:315–326.

    Article  PubMed  CAS  Google Scholar 

  143. Laster SB, Rutherford BD, Giorgi LV, et al. Results of direct percutaneous transluminal coronary angioplasty in octogenarians. Am J Cardiol. 1996;77:10–13.

    Article  PubMed  CAS  Google Scholar 

  144. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK (Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock). N Engl J Med. 1999;341:625–634.

    Article  PubMed  CAS  Google Scholar 

  145. Bueno H, López-Palop R, Bermejo J, et al. In-hospital outcome of elderly patients with acute inferior myocardial infarction and right ventricular involvement. Circulation. 1997;96:436–441.

    PubMed  CAS  Google Scholar 

  146. Weintraub RM, Wei JY, Thurer RL. Surgical repair of remediable postinfarction cardiogenic shock in the elderly: early and long-term results. J Am Geriatr Soc. 1986;34:389–392.

    PubMed  CAS  Google Scholar 

  147. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA. 1994;272:859–866.

    Article  PubMed  CAS  Google Scholar 

  148. Pashos CL, Newhouse JP, McNeil BJ. Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990. JAMA. 1993; 270:1832–1836.

    Article  PubMed  CAS  Google Scholar 

  149. Gottlieb S, Goldbourt U, Boyko V, et al., for the SPRINT and Thrombolytic Survey Groups. Improved outcome of elderly patients (≥75 years of age) with acute myocardial infarction from 1981–1983 to 1992–1994 in Israel. Circulation. 1997;95:342–350.

    PubMed  CAS  Google Scholar 

  150. Smith SC Jr, Gilpin E, Ahnve S, et al. Outlook after acute myocardial infarction in the very elderly compared with that in patients aged 65 to 75 years. J Am Coll Cardiol. 1990;16:784–792.

    PubMed  Google Scholar 

  151. Rogers WJ, Bowlby LJ, Chandra NC, et al., for the Participants in the National Registry of Myocardial Infarction. Treatment of myocardial infarction in the United States (1990–1993): observations from the National Registry of Myocardial Infarction. Circulation. 1994;90: 2103–2114.

    PubMed  CAS  Google Scholar 

  152. Krumholz HM, Radford MJ, Wang Y, et al. Earlyβ-blocker therapy for acute myocardial infarction in elderly patients. Ann Intern Med. 1999;131:648–654.

    PubMed  CAS  Google Scholar 

  153. Daida H, Kottke TE, Backes RJ, et al. Are coronary-care unit changes in therapy associated with improved survival of elderly patients with acute myocardial infarction? Mayo Clinic Proc. 1997;72:1014–1021.

    Article  CAS  Google Scholar 

  154. The First International Study of Infarct Survival (ISIS-I) Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction. Lancet. 1981;2:823–827.

    Google Scholar 

  155. Hjalmarson A, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial. Lancet. 1981;2:823–827.

    Article  PubMed  CAS  Google Scholar 

  156. The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI): a randomised placebo-controlled international trial. Eur Heart J. 1985;6: 199–226.

    Google Scholar 

  157. The International Collaborative Study Group. Reduction of infarct size with the early use of timolol in acute myocardial infarction. N Engl J Med. 1984;310:9–15.

    Article  Google Scholar 

  158. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. N Engl J Med. 1989;320:618–627.

    Article  Google Scholar 

  159. Gundersen T, Abrahamsen AM, Kjekshus J, et al., for the Norwegian Multicentre Study Grou. Timolol-related reduction in mortality and reinfarction in patients ages 65–75 years surviving acute myocardial infarction. Circulation. 1982;66:1179–1184.

    PubMed  CAS  Google Scholar 

  160. Pederson TR, for the Norwegian Multicenter Study Group. Six-year follow-up of the Norwegian multicenter study on timolol after acute myocardial infarction. N Engl J Med. 1985;313:1055–1058.

    Article  Google Scholar 

  161. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA. 1982; 247:1707–1714.

    Article  Google Scholar 

  162. Gurwitz JH, Goldberg RJ, Chen Z, et al. β-Blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. Am J Med. 1992;93:605–610

    Article  PubMed  CAS  Google Scholar 

  163. Soumerai SB, McLaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of β-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277 115–121.

    Article  PubMed  CAS  Google Scholar 

  164. Krumholz HM, Radford MJ, Wang Y, et al. National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction. National Cooperative Cardiovascular Project. JAMA. 1998;280:623–629.

    Article  PubMed  CAS  Google Scholar 

  165. Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br Med J. 1989;299:1187–1192.

    Article  CAS  Google Scholar 

  166. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;ii:349–360.

    Google Scholar 

  167. Krumholz HM, Radford MJ, Ellerbeck EF, et al. Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries: patterns of use and outcomes. Circulation. 1995;92:2841–2847.

    PubMed  CAS  Google Scholar 

  168. Krumholz HM, Radford MJ, Ellerbeck EF, et al. Aspirin for secondary prevention after acute myocardial infarction in the elderly. Prescribed use and outcomes. Ann Intern Med. 1996;124:292–298.

    PubMed  CAS  Google Scholar 

  169. Gruppo Italiano per lo Studio della Sopravvivenza nelľInfarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;3443:1115–1122.

    Google Scholar 

  170. Smith P. Arnesen H, Abdelnoor M. Effect of long-term anticoagulant therapy in subgroups after acute myocardial infarction. Arch Intern Med. 1992;152:993–997.

    Article  PubMed  CAS  Google Scholar 

  171. Second Report of the Sixty-Plus Reinfarction Study Research Group. Risk of long-term anticoagulant therapy in elderly patients after myocardial infarction. Lancet. 1982;1:64–68.

    Google Scholar 

  172. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781–788.

    Article  PubMed  CAS  Google Scholar 

  173. Josephson RA, Papa LA, Brooks MM, et al., for the CAST Investigators. Effect of age on postmyocardial infarction ventricular arrhythmias (Holter Registry Data from CAST I and CAST II). Am J Cardiol. 1995;76:710–713.

    Article  PubMed  CAS  Google Scholar 

  174. Majumdar SR, Gurwitz JH, Soumerai SB. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease. J Gen Intern Med. 1999;14:711–717.

    Article  PubMed  CAS  Google Scholar 

  175. Ciaroni S, Delonca J, Righetti A. Early exercise testing after acute myocardial infarction in the elderly: clinical evaluation and prognostic significance. Am Heart J. 1993; 126:304–311.

    Article  PubMed  CAS  Google Scholar 

  176. Maggioni AP, Turazza FM, Tavazzi L. Risk evaluation using exercise testing in elderly patients after acute myocardial infarction. Cardiol Elderly. 1995;3:88–93.

    Google Scholar 

  177. Nicod P, Gilpin E, Dittrich H, et al. Short-and long-term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patient population. Circulation. 1989;79:528–536.

    PubMed  CAS  Google Scholar 

  178. Camerieri A, Picano E, Landi P, et al., on behalf of the Echo Persantine Italian Cooperative (EPIC) Study Group. Prognostic value of dipyridamole echocardiography early after myocardial infarction in elderly patients. J Am Coll Cardiol. 1993;22:1809–1815.

    PubMed  CAS  Google Scholar 

  179. Chung MK, Bosner MS, McKenzie JP. Prognosis of patients ≥70 years of age with non-Q-wave acute myocardial infarction compared with younger patients with similar infarcts and with patients ≥70 years of age with Q-wave acute myocardial infarction. Am J Cardiol. 1995;75: 18–22.

    Article  PubMed  CAS  Google Scholar 

  180. Berkman LF, Leo-Summers L, Horwitz RI. Emotional support and survival after myocardial infarction: a prospective, population-based study of the elderly. Ann Intern Med. 1992;117:1003–1009.

    PubMed  CAS  Google Scholar 

  181. Wenger NK. Populations with special needs for exercise rehabilitation. Elderly coronary patients. In: Wenger NK, Hellerstein HK, eds. Rehabilitation of the Coronary Patient, 3rd Ed. New York: Churchill Livingstone, 1992: 415–420.

    Google Scholar 

  182. Lavie CJ, Milani RV. Effects of cardiac rehabilitation programs on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in a large elderly cohort. Am J Cardiol. 1995;76:177–179.

    Article  PubMed  CAS  Google Scholar 

  183. Ades PA, Waldmann ML, Poehlman ET, et al. Exercise conditioning in older coronary patients: submaximal lactate response and endurance capacity. Circulation. 1993;88:572–577.

    PubMed  CAS  Google Scholar 

  184. Lavie CJ, Milani RV. Benefits of cardiac rehabilitation and exercise training in elderly women. Am J Cardiol. 1997;79:664–666.

    Article  PubMed  CAS  Google Scholar 

  185. Pollock ML, Carroll JF, Graves JE, et al. Injuries and adherence to walk/jog and resistance training programs in the elderly. Med Sci Sports Exerc. 1991;23:1194–1200.

    PubMed  CAS  Google Scholar 

  186. Peterson ED, Cowper PA, Jollis JG, et al. Outcomes of coronary artery bypass graft surgery in 24,461 patients aged 80 years or older. Circulation. 1995;92(suppl II): 85–91.

    Google Scholar 

  187. O’Keefe JH Jr, Sutton MB, McCallister BD, et al. Coronary angioplasty versus bypass surgery in patients >70 years old matched for ventricular function. J Am Coll Cardiol. 1994;24:425–430.

    PubMed  Google Scholar 

  188. Morrison DA, Bies RD, Sacks J. Coronary angioplasty for elderly patients with “high risk” unstable angina: Short-term outcomes and long-term survival. J Am Coll Cardiol. 1997;29:339–344.

    Article  PubMed  CAS  Google Scholar 

  189. Weintraub WS, Clements SD, Ware J, et al. Coronary artery surgery in octogenarians. Am J Cardiol. 1991;68: 1530–1534.

    Article  PubMed  CAS  Google Scholar 

  190. Glower DD, Christopher TD, Milano CA, et al. Performance status and outcome after coronary artery bypass grafting in persons aged 80 to 93 years. Am J Cardiol. 1992; 70:567–571.

    Article  PubMed  CAS  Google Scholar 

  191. Ko W, Gold JP, Lazzaro R, et al. Survival analysis of octogenarian patients with coronary artery disease managed by elective coronary artery bypass surgery versus conventional medical treatment. Circulation. 1992;86(suppl II): II-191–II-97.

    CAS  Google Scholar 

  192. Tsai TP, Denton TA, Chaux A, et al. Results of coronary artery bypass grafting and/or aortic or mitral valve operation in patients ≥90 years of age. Am J Cardiol. 1994;74: 960–962.

    Article  PubMed  CAS  Google Scholar 

  193. Gersh BJ, Kronmal RA, Schaff HV, et al. Long-term (5-year) results of coronary bypass surgery in patients 65 years or older: a report from the Coronary Artery Surgery Study. Circulation. 1983;68(suppl II): II-190–II-199.

    CAS  Google Scholar 

  194. Barzilay JI, Kronmal RA, Bittner V, et al. Coronary artery disease and coronary artery bypass grafting in diabetic patients aged ≥65 years (report from the Coronary Artery Surgery Study [CASS] Registry). Am J Cardiol. 1994;74: 334–339.

    Article  PubMed  CAS  Google Scholar 

  195. Noyez L, van der Werf T, Remmen GHJ, et al. Importance of the internal mammary artery for coronary bypass grafting in patients aged ≥70 years. Am J Cardiol. 1995;75: 734–736.

    Article  PubMed  CAS  Google Scholar 

  196. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol. 1999;34: 1262–1347.

    Article  PubMed  CAS  Google Scholar 

  197. Naunheim KS, Dean PA, Firoe AC, et al. Cardiac surgery in the octogenarian. Eur J Cardiothorac Surg. 1990;4: 130–135.

    Article  PubMed  CAS  Google Scholar 

  198. Katz ES, Tunick PA, Rusinek H, et al. Protruding aortic atheromas predict stroke in elderly patients undergoing cardiopulmonary bypass: experience with intraoperative transesophageal echocardiography. J Am Coll Cardiol 1992;20:70–77.

    PubMed  CAS  Google Scholar 

  199. Newman MF, Croughwell ND, Blumenthal JA, et al. Effect of aging on cerebral autoregulation during cardiopulmonary bypass: association with postoperative cognitive dysfunction. Circulation. 1994;90(suppl II): II-243–II-249.

    CAS  Google Scholar 

  200. Horvath KA, DiSesa VJ, Peigh PS, et al. Favorable results of coronary artery bypass grafting in patients older than 75 years. J Thorac Cardiovasc Surg. 1990;99:92–96.

    PubMed  CAS  Google Scholar 

  201. Gersh BJ, Kronmal RA, Schaff HV, et al., and participants in the CASS Study. Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older: a nonrandomized study from the Coronary Artery Surgery Study (CASS) Registry. N Engl J Med. 1985;313: 217–224.

    Article  PubMed  CAS  Google Scholar 

  202. Freeman WK, Schaff HV, O’Brien PC, et al. Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up. J Am Coll Cardiol. 1991;18:29–35.

    PubMed  CAS  Google Scholar 

  203. Hirose H, Amano A, Yoshida S, et al. Coronary artery bypass grafting in the elderly. Chest. 2000;117:1262–1270.

    Article  PubMed  CAS  Google Scholar 

  204. Jaeger AA, Hlatky MA, Paul SM, et al. Functional capacity after cardiac surgery in elderly patients. J Am Coll Cardiol. 1994;24:104–108.

    PubMed  CAS  Google Scholar 

  205. Kelsey SF, Miller DP, Holubkov R, et al. Results of percutaneous transluminal coronary angioplasty in patients ≥65 years of age (from the 1985 to 1986 National Heart, Lung, and Blood Institute’s Coronary Angioplasty Registry). Am J Cardiol. 1990;66:1033–1038.

    Article  PubMed  CAS  Google Scholar 

  206. Bedotto JB, Rutherford BD, McConahay DR, et al. Results of multivessel percutaneous transluminal coronary angioplasty in persons aged 65 years and older. Am J Cardiol 1991;67:1051–1055.

    Article  PubMed  CAS  Google Scholar 

  207. Jackman JD, Navetta FI, Smith JE, et al. Percutaneous transluminal coronary angioplasty in octogenarians as an effective therapy for angina pectoris. Am J Cardiol. 1991; 68:116–119.

    Article  PubMed  Google Scholar 

  208. ten Berg JM, Voors AA, Suttorp MJ, et al. Long-term results after successful percutaneous transluminal coronary angioplasty in patients over 75 years of age. Am J Cardiol. 1996;77:690–695.

    Article  PubMed  Google Scholar 

  209. Tan KH, Sulke N, Taub N, et al. Percutaneous transluminal coronary angioplasty in patients 70 years of age or older: 12 year’ experience. Br Heart J. 1995;74:310–317.

    PubMed  CAS  Google Scholar 

  210. Thompson RC, Holmes DR Jr, Grill DE, et al. Changing outcome of angioplasty in the elderly. J Am Coll Cardiol. 1996;27:8–14.

    Article  PubMed  CAS  Google Scholar 

  211. Macaya C, Alfonso F, Iniguez A, et al. Long-term clinical and angiographic follow-up of percutaneous transluminal coronary angioplasty in patients ≥65 years of age. Am J Cardiol. 1990;66:1513–1515.

    Article  PubMed  CAS  Google Scholar 

  212. Taddei CFG, Weintraub WS, Douglas JS Jr, et al. Influence of age on outcome after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1999;84:245–251.

    Article  PubMed  CAS  Google Scholar 

  213. Thompson RC, Holmes DR Jr, Gersh BJ, et al. Percutaneous transluminal coronary angioplasty in the elderly: early and long-term results J Am Coll Cardiol. 1991;17: 1245–1250.

    PubMed  CAS  Google Scholar 

  214. Weyrens FJ, Goldenberg I, Mooney JF, et al. Percutaneous transluminal coronary angioplasty in patients aged ≥90 years. Am J Cardiol. 1994;74:397–398.

    Article  PubMed  CAS  Google Scholar 

  215. Popma JJ, Satler LF, Mintz GS, et al. Coronary angioplasty and new device therapy. Cardiol Elderly. 1993;1:62–70.

    Google Scholar 

  216. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly. Hypertension. 1994;23:275–285.

    Google Scholar 

  217. Staessen J, Amery A, Fagard R. Editorial review. Isolated systolic hypertension in the elderly. J Hypertens. 1990;8: 393–405.

    PubMed  CAS  Google Scholar 

  218. Pasierski T, Pearson AC, Labovitz AJ. Pathophysiology of isolated systolic hypertension in elderly patients: Doppler echocardiographic insights. Am Heart J. 1991;122:528–534.

    Article  PubMed  CAS  Google Scholar 

  219. Bots ML, Witteman JCM, Hofman A, et al. Low diastolic blood pressure and atherosclerosis in elderly subjects: the Rotterdam Study. Arch Intern Med. 1996;156:843–848.

    Article  PubMed  CAS  Google Scholar 

  220. Reaven PD, Barrett-Connor E, Edelstein S. Relation between leisure-time physical activity and blood pressure in older women. Circulation. 1991;83:559–565.

    PubMed  CAS  Google Scholar 

  221. Applegate WB. Hypertension in elderly patients. Ann Intern Med. 1989;110:901–915.

    PubMed  CAS  Google Scholar 

  222. Amery A, Birkenhäger W, Brixko R, et al. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet. 1986;2:589–592.

    Article  PubMed  CAS  Google Scholar 

  223. Staessen JA, Thijs L, Fagard R, et al., for the Systolic Hypertensions in Europe Trial Investigators. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA. 1999;282:539–546.

    Article  PubMed  CAS  Google Scholar 

  224. Sagie A, Benjamin EJ, Galderisi M, et al. Echocardio-graphic assessment of left ventricular structure and diastolic filling in elderly subjects with borderline isolated systolic hypertension (the Framingham Heart Study). Am J Cardiol. 1993;72:662–665.

    Article  PubMed  CAS  Google Scholar 

  225. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413–2446.

    Article  Google Scholar 

  226. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. III: Influence of age, diastolic pressure, and prior cardiovascular disease: further analysis of side effects. Circulation 1972;45:991–1004.

    Google Scholar 

  227. Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet. 1985;1: 1349–1354.

    Article  PubMed  CAS  Google Scholar 

  228. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255–3264.

    Article  Google Scholar 

  229. Kostis JB, Davis BR, Cutler J, et al., for the SHEP Cooperative Research Group. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1997;278:212–216.

    Article  PubMed  CAS  Google Scholar 

  230. Curb JD, Pressel SL, Cutler JA, et al., for the Systolic Hypertension in the Elderly Program Cooperative Research Group. Effect of diuretic-based antihyperten-sive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA. 1996;276:1886–1892.

    Article  PubMed  CAS  Google Scholar 

  231. Wassertheil-Smoller S, Applegate WB, Berg K, et al., for the SHEP Cooperative Research Group. Change in depression as a precursor of cardiovascular events. Arch Intern Med. 1996;156:553–561.

    Article  PubMed  CAS  Google Scholar 

  232. National Intervention Cooperative Study in Elderly Hypertensives Study Group. Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. Hypertension 1999;34:1129–1133.

    Google Scholar 

  233. Whelton PK, Appel LJ, Espeland MA, et al., for the TONE Collaborative Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled Trial of Nonpharmacologic Interventions in the Elderly (TONE). JAMA. 1998; 279:839–846.

    Article  PubMed  CAS  Google Scholar 

  234. Gurwitz JH, Everitt DE, Monane M, et al. The impact of ibuprofen on the efficacy of antiyhypertensive treatment with hydrochlorothiazide in elderly persons. J Gerontol 1996;51A:M74–M79.

    CAS  Google Scholar 

  235. Mulrow CD, Cornell JA, Herrera CR, et al. Hypertension in the elderly: implications and generalizability of randomized trials. JAMA. 1994;272:1932–1938.

    Article  PubMed  CAS  Google Scholar 

  236. Pahor M, Guralnik JM, Furberg CD, et al. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet. 1996;347: 1061–1065.

    Article  PubMed  CAS  Google Scholar 

  237. MacMahon S, Rodgers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens. 1993;15:967–978.

    PubMed  CAS  Google Scholar 

  238. Elliott WJ, Weir DR, Black HR. Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hyperten-sive patients. Arch Intern Med. 2000;160:1277–1283.

    Article  PubMed  CAS  Google Scholar 

  239. Culliford AT, Galloway AC, Colvin SB, et al. Aortic valve replacement for aortic stenosis in persons aged 80 years and over. Am J Cardiol. 1991;67:1256–1260.

    Article  PubMed  CAS  Google Scholar 

  240. Nylander E, Ekman I, Marklund T, et al. Severe aortic stenosis in elderly patients. Br Heart J. 1986;55:480–487.

    PubMed  CAS  Google Scholar 

  241. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J. 1988;9(suppl E):57–64.

    PubMed  Google Scholar 

  242. Iivanainen AM, Lindroos M, Tilvis R, et al. Natural history of aortic valve stenosis of varying severity in the elderly. Am J Cardiol. 1996;78:97–101.

    Article  PubMed  CAS  Google Scholar 

  243. Lombard JT, Selzer A. Valvular aortic stenosis: a clinical and hemodynamic profile of patients. Ann Intern Med 1987;106:292–298.

    PubMed  CAS  Google Scholar 

  244. Lund O, Nielsen TT, Magnussen K, et al. Valve replacement for calcified aortic stenosis in septuagenarians infers normal life-length. Scand J Thorac Cardiovasc Surg. 1991; 25:37–44.

    PubMed  CAS  Google Scholar 

  245. Bonow RO, Carabello B, de Leon AC Jr, et al. ACC/AHA guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation. 1998;98:1949–1984.

    PubMed  CAS  Google Scholar 

  246. Turina J, Hess O, Sepulcri F, et al. Spontaneous course of aortic valve disease. Eur Heart J. 1987;8:471–483.

    PubMed  CAS  Google Scholar 

  247. Aranki SF, Rizzo RJ, Couper GS, et al. Aortic valve replacement in the elderly. Effect of gender and coronary artery disease on operative mortality. Circulation. 1993; 88(part 2):17–23.

    Google Scholar 

  248. Verheul HA, van den Brink RBA, Bouma BJ, et al. Analysis of risk factors for excess mortality after aortic valve replacement. J Am Coll Cardiol. 1995;26:1280–1286

    Article  PubMed  CAS  Google Scholar 

  249. Elayda MacAA, Hall RJ, Reul RM, et al. Aortic valve replacement in patients 80 years and older: operative risks and long-term results. Circulation. 1993;88(part 2): 11–16.

    Google Scholar 

  250. Craver JM, Weintraub WS, Jones EL, et al. Predictors of mortality, complications, and length of stay in aortic valve replacement for aortic stenosis. Circulation. 1988; 78(suppl I):I-85–I-90.

    CAS  Google Scholar 

  251. Logeais Y, Langanay T, Roussin R, et al. Surgery for aortic stenosis in elderly patients: a study of surgical risk and predictive factors. Circulation. 1994;90:2891–2898.

    PubMed  CAS  Google Scholar 

  252. Glock Y, Faik M, Laghzaoui A, et al. Cardiac surgery in the ninth decade of life. Cardiovasc Surg. 1996;4:241–245.

    Article  PubMed  CAS  Google Scholar 

  253. Zaidi AM, Fitzpatrick AP, Keenan DJM, et al. Good outcomes from cardiac surgery in the over-70s. Heart. 1999;82:134–137.

    PubMed  CAS  Google Scholar 

  254. Kolh P, Lahaye L, Gerard P, et al. Aortic valve replacement in the octogenarians: perioperative outcome and clinical follow-up. Eur J Cardiothorac Surg. 1999;16:68–73.

    Article  PubMed  CAS  Google Scholar 

  255. Tseng EE, Lee CA, Cameron DE, et al. Aortic valve replacement in the elderly: risk factors and long-term results. Ann Surg. 1997;225:793–804.

    Article  PubMed  CAS  Google Scholar 

  256. Cohen G, David TE, Ivanov J, et al. The impact of age, coronary artery disease, and cardiac comorbidity on late survival after bioprosthetic aortic valve replacement. J Thorac Cardiovasc Surg. 1999;117:273–284.

    Article  PubMed  CAS  Google Scholar 

  257. McKay CR, Waller BF. Current status of balloon valvuloplasty. Cardiol Elderly. 1993;1:77–85.

    Google Scholar 

  258. O’Neill WW, for the Mansfield Scientific Aortic Valvuloplasty Registry Investigators. Predictors of long-term survival after percutaneous aortic valvuloplasty: report of the Mansfield Scientific Balloon Aortic Valvuloplasty Registry. J Am Coll Cardiol. 1991;17:193–198.

    PubMed  CAS  Google Scholar 

  259. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty: insights into prognosis of valvular aortic stenosis. Circulation. 1994;89: 642–650.

    PubMed  CAS  Google Scholar 

  260. Cheitlin MD. Valve disease in the octogenarian. In: Wenger NK, ed. Cardiovascular Disease in the Octogenarian and Beyond. London: Dunitz;1999:255–266.

    Google Scholar 

  261. Scognamiglio R, Rahimtoola SH, Fasoli G, et al. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med. 1994;331:689–694.

    Article  PubMed  CAS  Google Scholar 

  262. Lee EM, Porter JN, Shapiro LM, et al. Mitral valve surgery in the elderly. J Heart Valve Dis. 1997;6:22–31.

    PubMed  CAS  Google Scholar 

  263. Kolibash AJ, Bush CA, Fontana MB, et al. Mitral valve prolapse syndrome: analysis of 62 patients aged 60 years and older. Am J Cardiol. 1983;52:534–539.

    Article  PubMed  CAS  Google Scholar 

  264. Nair CK, Biddle P, Kaneshige A, et al. Ten-year experience with mitral valve replacement in elderly. Am Heart J. 1992; 124:154–159.

    Article  PubMed  CAS  Google Scholar 

  265. Bolling SF, Deeb M, Bach DS. Mitral valve reconstruction in elderly, ischemic patients. Chest. 1996;109:35–40.

    PubMed  CAS  Google Scholar 

  266. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA. 1997;277:1794–1801.

    Article  PubMed  CAS  Google Scholar 

  267. Ofili EO, Rich MI, Brown P, et al. Safety and usefulness of transesophageal echocardiography in persons aged ≥70 years. Am J Cardiol. 1990;66:1279–1280.

    Article  PubMed  CAS  Google Scholar 

  268. Le Feuvre C, Bonan R, Lachurie M-L, et al. Balloon mitral commissurotomy in patients aged ≥70 years. Am J Cardiol. 1993;71:233–236.

    Article  PubMed  Google Scholar 

  269. Meneveau N, Schiele F, Seronde M-F, et al. Predictors of event-free survival after percutaneous mitral commissurotomy. Heart. 1998;80:359–364.

    PubMed  CAS  Google Scholar 

  270. Cheitlin MD. Congenital heart disease in the adult. Mod Conc Cardiovasc Dis. 1986;55:20–24.

    Google Scholar 

  271. Werner GS, Schulz R, Fuchs JB, et al. Infective endocarditis in the elderly in the era of transesophageal echocardiography: clinical features and prognosis compared with younger patients. Am J Med. 1996;100:90–97.

    Article  PubMed  CAS  Google Scholar 

  272. Terpenning MS, Buggy BP, Kauffman CA. Infective endocarditis: clinical features in young and elderly patients. Am J Med. 1987;83:626–634.

    Article  PubMed  CAS  Google Scholar 

  273. Selton-Suty C, Hoen B, Grentzinger A, et al. Clinical and bacteriological characteristics of infective endocarditis in the elderly. Heart. 1997;77:260–263.

    Article  PubMed  CAS  Google Scholar 

  274. Kearney RA, Eisen HJ, Wolf JE. Nonvalvular infections of the cardiovascular system. Ann Intern Med. 1994;121:219–230.

    PubMed  CAS  Google Scholar 

  275. Krasnow N, Stein RA. Hypertrophic cardiomyopathy in the aged. Am Heart J. 1978;96:326–336.

    Article  PubMed  CAS  Google Scholar 

  276. Fay WP, Taliercio CP, Ilstrup DM, et al. Natural history of hypertrophic cardiomyopathy in the elderly. J Am Coll Cardiol. 1990;16:821–826.

    Article  PubMed  CAS  Google Scholar 

  277. Lever HM, Karam RF, Currie PJ, et al. Hypertrophic cardiomyopathy in the elderly: distinctions from the young based on cardiac shape. Circulation. 1989;79:580–589.

    PubMed  CAS  Google Scholar 

  278. Pearson AC, Gudipati CV, Labovitz AJ. Systolic and diastolic flow abnormalities in elderly patients with hypertensive hypertrophic cardiomyopathy. J Am Coll Cardiol. 1988;12:989–995.

    PubMed  CAS  Google Scholar 

  279. Lewis JF, Maron BJ. Clinical and morphologic expression of hypertrophic cardiomyopathy in patients ≥65 years of age. Am J Cardiol. 1994;73:1105–1111.

    Article  PubMed  CAS  Google Scholar 

  280. Koch J-P, Maron BJ, Epstein ES, et al. Results of operation for obstructive hypertrophic cardiomyopathy in the elderly: septal myotomy and myectomy in 20 patients 65 years of age or older. Am J Cardiol. 1980;46: 963–966.

    Article  PubMed  CAS  Google Scholar 

  281. Coughlin SS, Tefft MC, Rice JC, et al. Epidemiology of idiopathic dilated cardiomyopathy in the elderly: pooled results from two case-control studies. Am J Epidemiol. 1996;143:881–888.

    PubMed  CAS  Google Scholar 

  282. Shah PM, Abelmann WH, Gersh BJ. 18th Bethesda Conference: Cardiovascular Disease in the Elderly. Cardiomyopathies in the elderly. J Am Coll Cardiol. 1987; 10(suppl A):77A–79A.

    PubMed  CAS  Google Scholar 

  283. Stein PD, Gottschalk A, Saltzman HA, et al. Diagnosis of acute pulmonary embolism in the elderly. J Am Coll Cardiol. 1991;18:1452–1457.

    PubMed  CAS  Google Scholar 

  284. Kniffin WD Jr, Baron JA, Barrett J, et al. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med. 1994;154:861–866.

    Article  PubMed  Google Scholar 

  285. Siddique RM, Siddique MI, Connors AF Jr, et al. Thirtyday case-fatality rates for pulmonary embolism in the elderly. Arch Intern Med. 1996;156:2343–2347.

    Article  PubMed  CAS  Google Scholar 

  286. Braman SS, Eby E, Kuhn C, et al. Primary pulmonary hypertension in the elderly. Arch Intern Med. 1991;151: 2433–2438.

    Article  PubMed  CAS  Google Scholar 

  287. Mangano DT. Perioperative cardiac morbidity. Anesthesiology. 1900;72:153–184.

    Google Scholar 

  288. Eagle KA, Brundage BH, Chaitman BR, et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 1996;93: 1278–1317.

    PubMed  CAS  Google Scholar 

  289. Wasserman K. Preoperative evaluation of cardiovascular reserve in the elderly. Chest. 1993;104:663–664.

    PubMed  CAS  Google Scholar 

  290. Foster ED, David KB, Carpenter JA, et al. Risk of non-cardiac operation in patients with defined coronary disease: the Coronary Artery Surgery Study (CASS) Registry experience. Ann Thorac Surg. 1986;41:42–50.

    Article  PubMed  CAS  Google Scholar 

  291. Gersh BJ, Rihal CS, Rooke TW, et al. Evaluation and management of patients with both peripheral vascular and coronary artery disease. J Am Coll Cardiol. 1991;18:203–214.

    PubMed  CAS  Google Scholar 

  292. Towne JB, Weiss DG, Hobson RW II. First phase report of Cooperative Veterans Administration asymptomatic carotid stenosis study: operative morbidity and mortality. J Vasc Surg. 1990;11:252–259.

    Article  PubMed  CAS  Google Scholar 

  293. World Health Organization Study Group. Epidemiology and Prevention of Cardiovascular Diseases in Elderly People. WHO Technical Report Series 853. Geneva: World Health Organization; 1995.

    Google Scholar 

  294. Tervahauta M, Pekkanen J, Nissinen A. Risk factors of coronary heart disease and total mortality among elderly men with and without preexisting coronary heart disease: the Finnish Cohorts of the Seven Countries Study. J Am Coll Cardiol. 1995;26:1623–1629.

    Article  PubMed  CAS  Google Scholar 

  295. The Clinical Quality Improvement Network (CQIN) Investigators. Low incidence of assessment and modification of risk factors in acute care patients at high risk for cardiovascular events, particularly among females and the elderly. Am J Cardiol. 1995;76:570–573.

    Google Scholar 

  296. Masaki KH, Petrovitch H, Rodriquez BL, et al. The value of risk factor modification in old age. Cardiol Elderly. 1993;1:391–397.

    Google Scholar 

  297. Kuller L, Borhani N, Furberg C, et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol 1994;139:1164–1179.

    PubMed  CAS  Google Scholar 

  298. Fried LP, Kronmal RA, Newman AB, et al., for the Cardiovascular Health Study Collaborative Research Group. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA. 1998;279:585–592.

    Article  PubMed  CAS  Google Scholar 

  299. Tracy RP, Arnold AM, Ettinger W, et al. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999;19:1776–1783.

    PubMed  CAS  Google Scholar 

  300. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 1997;17:1121–1127.

    PubMed  CAS  Google Scholar 

  301. Kannel WB, Doyle JT, Shephard RJ, et al. 18th Bethesda Conference: Cardiovascular Disease in the Elderly. Prevention of cardiovascular disease in the elderly. J Am Coll Cardiol. 1987;10(suppl A):25A–28A.

    Article  PubMed  CAS  Google Scholar 

  302. Corti M-C, Guralnik JM, Salive ME, et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med. 1997;126:753–760.

    PubMed  CAS  Google Scholar 

  303. Weijenberg MP, Feskens EJM, Kromhout D. Total and high density lipoprotein cholesterol as risk factors for coronary heart disease in elderly men during 5 years of follow-up: the Zutphen Elderly Study. Am J Epidemiol. 1996;143:151–158.

    PubMed  CAS  Google Scholar 

  304. Snowdon DA, Phillips Rl, Fraser GE. Meat consumption and fatal ischemic heart disease. Prev Med. 1984;13:490–500.

    Article  PubMed  CAS  Google Scholar 

  305. The Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015–3025.

    Article  Google Scholar 

  306. Denke MA, Grundy SM. Hypercholesterolemia in elderly persons:resolving the treatment dilemma. Ann Intern Med. 1990;112:780–792.

    PubMed  CAS  Google Scholar 

  307. Carlson LA, Rosenhamer G. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand. 1988;223:405–418.

    Article  PubMed  CAS  Google Scholar 

  308. Pacala JT, McBride PE, Grady SL. Management of older adults with hypercholesterolaemia. Drugs Aging. 1994;4: 366–378.

    PubMed  CAS  Google Scholar 

  309. Santinga JT, Rosman HS, Rubenfire M, et al. Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia. Am J Med. 1994;96: 509–515.

    Article  PubMed  CAS  Google Scholar 

  310. Hulley SB, Newman TB. Cholesterol in the elderly: is it important? JAMA. 1994;272:1372–1374.

    Article  PubMed  CAS  Google Scholar 

  311. Scandinavian Simvastatin Survival Study group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–1389.

    Google Scholar 

  312. Jajich CL, Ostfeld AM, Freeman DH Jr. Smoking and coronary heart disease mortality in the elderly. JAMA. 1984;252:2831–2834.

    Article  PubMed  CAS  Google Scholar 

  313. LaCroix AZ, Lang J, Scherr P, et al. Smoking and mortality among older men and women in three communities. N Engl J Med. 1991;324:1619–1625.

    Article  Google Scholar 

  314. Hermanson B, Omenn GS, Kronmal RA, et al., and participants in the Coronary Artery Surgery Study. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS Registry. N Engl J Med. 1988;319:1365–1369.

    Article  PubMed  CAS  Google Scholar 

  315. Ades PA, Ballor DL, Ashikaga T, et al. Weight training improves walking endurance in healthy elderly persons. Ann Intern Med. 1996;124:568–572.

    PubMed  CAS  Google Scholar 

  316. Paffenbarger RS Jr, Hyde RT, Wing AL, et al. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med. 1986;314:605–613.

    Article  PubMed  Google Scholar 

  317. Braith RW, Pollock ML, Lowenthal DT, et al. Moderate-and high-intensity exercise lowers blood pressure in normotensive subjects 60 to 79 years of age. Am J Cardiol. 1994;73:1124–1128.

    Article  PubMed  CAS  Google Scholar 

  318. Wenger NK. Physical inactivity and coronary heart disease in elderly patients. Clin Geriatr Med. 1996;12:79–88.

    PubMed  CAS  Google Scholar 

  319. Fiatarone MA, O’Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med. 1994;330: 1769–1775.

    Article  PubMed  CAS  Google Scholar 

  320. Manolio TA, Furberg CD, Shemanski L, et al., for the CHS Collaborative Research Group. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation. 1993;88(part 1): 2163–2171.

    PubMed  CAS  Google Scholar 

  321. Hertog MGL, Feskens EJM, Hollman PCH, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993;342:1007–1011.

    Article  PubMed  CAS  Google Scholar 

  322. Schauffler HH, D’Agostino RB, Kannel WB. Risk for cardiovascular disease in the elderly and associated Medicare costs: the Framingham Study. Am J Prev Med. 1993;9: 146–154.

    PubMed  CAS  Google Scholar 

  323. Wenger NK, ed. Proceedings from the Millennium Symposium: Heart disease in the octogenarian, March 11, 2000. Am J Geriatr Cardiol. 2000;9:1–112.

    Google Scholar 

Download references

Authors
  1. Nanette Kass Wenger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Wenger, N.K. (2003). Cardiovascular Disease. In: Geriatric Medicine. Springer, New York, NY. https://doi.org/10.1007/0-387-22621-4_40

Download citation

  • DOI: https://doi.org/10.1007/0-387-22621-4_40

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95514-8

  • Online ISBN: 978-0-387-22621-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation